Clark Williard

Statistics

Publications

Citations

434

H-Index

Active since

2005

Affiliations

Charles River Laboratories (United States)(Current)

WuXi AppTec (United States)

Shawnee Mission Medical Center

University of Colorado Colorado Springs

Princeton University

Clark Williard is an author at Charles River Laboratories (United States) specializing in medicine, assay validation, and bioanalytical method validation.

Publications per year

2005–2022

Publications

Variation in Anastrozole Metabolism and Pharmacodynamics in Women with Early Breast Cancer

James N. Ingle, Aman U. Buzdar, Daniel J. Schaid et al. · Cancer Research · 2010 · 69 citations

Medicine, Oncology, Pharmacology +16

Sirolimus PK trial: A pharmacokinetic study of the sirolimus‐eluting Bx Velocity stent in patients with de novo coronary lesions

George W. Vetrovec, David G. Rizik, Clark Williard et al. · Catheterization and Cardiovascular Interventions · 2005 · 54 citations

Medicine, Clinical Pharmacokinetics, Pharmacology +15

Recommendations on qPCR/ddPCR Assay Validation by GCC

Mark Wissel, Martin Poirier, Christina Satterwhite et al. · Bioanalysis · 2022 · 52 citations

Pharmacy, Biotechnology, Good Laboratory Practice +12

TSPYL5 SNPs: Association with Plasma Estradiol Concentrations and Aromatase Expression

Mohan Liu, James N. Ingle, Brooke L. Fridley et al. · Molecular Endocrinology · 2013 · 51 citations · Full text

Medicine, Endocrinology, Genetics +14

Estrogens and their precursors in postmenopausal women with early breast cancer receiving anastrozole

James N. Ingle, Krishna R. Kalari, Aman U. Buzdar et al. · Steroids · 2014 · 44 citations · Full text

Medicine, Endocrinology, Oncology +14

1–5 of 14